Arabic Arabic English English French French German German
dark

Public Meeting on Patient Focused Drug Development for Inborn Errors of Metabolism Part 2

On June 10, 2014, FDA hosted a public meeting on Patient-Focused Drug Development for Inborn Errors of Metabolism. FDA was interested in obtaining patient perspectives on the impact of Inborn Errors of Metabolism on daily life and patient views on treatment approaches. For more information, visit https://go.usa.gov/x69cX.

Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Public Meeting on Patient Focused Drug Development for Inborn Errors of Metabolism Part 1

Next Post

Opt-Out Increases Hepatitis C Screening Uptake

Related Posts
Total
0
Share